By combination of expression analysis and survival analysis (Figure 7A), we found that nine lncRNAs, including SNHG1 (Figure 7B), SNHG12 (Figure 7C), LINC00511 (Figure 7D), HCG18 (Figure 7E), FGD5-AS1 (Figure 7F), CERS6-AS1 (Figure 7G), NUTM2A-AS1 (Figure 7H), SNHG16 (Figure 7I), and ASB16-AS1 (Figure 7J), were significantly upregulated in hepatocellular carcinoma, and their upregulation linked to poor prognosis of patients with hepatocellular carcinoma. Here, NUTM2A is linked to hepatocellular carcinoma.